Retatrutide

from $90.00

Retatrutide is an investigational synthetic peptide classified as a triple incretin receptor agonist, designed to activate glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. This multi-receptor agonism makes it a unique compound of interest in metabolic research, particularly in studies examining glucose regulation, energy expenditure, lipid metabolism, and body weight dynamics.

Laboratory research into Retatrutide has focused on its ability to integrate multiple metabolic pathways simultaneously, providing insight into the combined effects of incretin and glucagon signaling on insulin sensitivity, appetite regulation, and thermogenesis. Comparative studies with single- and dual-agonist peptides highlight its potential as a tool for advancing the understanding of complex metabolic disorders and energy balance.

MG:

Retatrutide is an investigational synthetic peptide classified as a triple incretin receptor agonist, designed to activate glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. This multi-receptor agonism makes it a unique compound of interest in metabolic research, particularly in studies examining glucose regulation, energy expenditure, lipid metabolism, and body weight dynamics.

Laboratory research into Retatrutide has focused on its ability to integrate multiple metabolic pathways simultaneously, providing insight into the combined effects of incretin and glucagon signaling on insulin sensitivity, appetite regulation, and thermogenesis. Comparative studies with single- and dual-agonist peptides highlight its potential as a tool for advancing the understanding of complex metabolic disorders and energy balance.